Dr. Bai’s research focuses on advancing nanotechnology and biotechnology to overcome the challenges of targeted and controlled drug delivery. His work integrates synthetic and natural nanoplatforms to enhance therapeutic efficacy by addressing drug delivery issues such as poor absorption, instability, and lack of disease specificity. Key areas of expertise include non-viral gene delivery carriers for improved gene encapsulation, sustained-release liposomes and microemulsions, and exosome-based nanocarriers for precision drug targeting. His approaches combine material science, cell bioengineering, and advanced drug delivery systems to achieve precise temporal and spatial delivery of proteins, siRNAs, mRNA, and gene therapies.